BridgeBio Pharma (BBIO) Cash & Equivalents Growth (1y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -68.22% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 988.88% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.00% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 15.64% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 4.77% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 17.50% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 3.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -4.13% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 67.78% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | 62.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 62.76% |
| Dec 31, 2025 | -16.29% |
| Sep 30, 2025 | 6.39% |
| Jun 30, 2025 | 83.59% |
| Mar 31, 2025 | 13.76% |
| Dec 31, 2024 | 81.18% |
| Sep 30, 2024 | -47.28% |
| Jun 30, 2024 | 34.89% |
| Mar 31, 2024 | 16.66% |
| Dec 31, 2023 | -0.20% |
| Sep 30, 2023 | 4.55% |
| Jun 30, 2023 | -35.66% |
| Mar 31, 2023 | 9.64% |
| Dec 31, 2022 | -4.34% |
| Sep 30, 2022 | 167.95% |
| Jun 30, 2022 | 24.23% |
| Mar 31, 2022 | -21.14% |
| Dec 31, 2021 | 283,189.21% |
| Sep 30, 2021 | -50.85% |
| Jun 30, 2021 | -30.04% |
| Mar 31, 2021 | -37.76% |
| Dec 31, 2020 | -99.96% |
| Sep 30, 2020 | -11.35% |
| Jun 30, 2020 | 84.11% |
| Mar 31, 2020 | 102.95% |
| Dec 31, 2019 | -16.58% |
| Sep 30, 2019 | 95.52% |
| Jun 30, 2019 | 16.41% |
| Dec 31, 2018 | 374.03% |